Related Experiment Video
Updated: Aug 1, 2025
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
457
Outcome measures in Behçet syndrome.
1Division of Rheumatology, Department of Internal Medicine, Istanbul University, Cerrahpaşa, Turkey.
Clinical Immunology (Orlando, Fla.)
|April 26, 2023
Summary
Assessing Behçet syndrome is difficult due to its varied symptoms and organ involvement. Recent advancements in outcome measures offer improved assessment tools for this complex systemic vasculitis.
Area of Science:
- Rheumatology and Immunology
- Clinical Trial Design
- Patient-Reported Outcomes
Background:
- Behçet syndrome presents a diagnostic challenge due to its heterogeneous clinical manifestations and multiorgan involvement.
- Variable treatment responses complicate disease assessment and monitoring in clinical practice.
- Existing outcome measures often lack standardization and comprehensive validation for Behçet syndrome.
Approach:
- This review synthesizes recent developments in Behçet syndrome outcome measures, including core domain sets and organ-specific instruments.
- It critically evaluates the current landscape of assessment tools for disease activity, damage, and treatment efficacy.
- The review identifies unmet needs in outcome measure development and proposes a future research agenda.
Key Points:
- Development of a Behçet syndrome Core Set of Domains represents a significant step towards standardized assessment.
- Novel instruments for evaluating specific organ involvement (e.g., ocular, neurological) enhance disease characterization.
- Addressing overall damage and long-term sequelae requires further refinement of existing and new outcome measures.
Conclusions:
- Standardized and validated outcome measures are crucial for advancing Behçet syndrome research and clinical care.
- Future research should focus on developing comprehensive instruments that capture the full spectrum of disease impact.
- A collaborative, international effort is needed to establish universally accepted outcome measures for Behçet syndrome.
More Related Videos
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
164
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
164
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
209
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
209